Y-Intercept (HK)’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
+165,879
New +$1.39M 0.03% 892
2026
Q1
Sell
-14,011
Closed -$173K 1670
2025
Q4
$173K Sell
14,011
-3,577
-20% -$38.3K ﹤0.01% 1448
2025
Q3
$155K Buy
+17,588
New +$137K ﹤0.01% 1480
2025
Q2
Sell
-95,026
Closed -$462K 1715
2025
Q1
$462K Buy
+95,026
New +$787K 0.03% 727
2024
Q3
Sell
-16,233
Closed -$111K 1436
2024
Q2
$111K Buy
+16,233
New +$69.9K 0.01% 1251
2023
Q4
Sell
-75,362
Closed -$256K 1330
2023
Q3
$256K Buy
+75,362
New +$418K 0.03% 826
2023
Q1
Sell
-24,009
Closed -$284K 1259
2022
Q4
$284K Buy
24,009
+8,831
+58% +$137K 0.04% 685
2022
Q3
$319K Buy
+15,178
New +$422K 0.03% 684

Other funds holding EBS